PMC:7247521 / 993-1888
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
29 | 155-161 | Gene | denotes | MIR183 | Gene:406959 |
30 | 172-176 | Gene | denotes | CDK7 | Gene:1022 |
31 | 263-267 | Gene | denotes | ACE2 | Gene:59272 |
32 | 667-676 | Gene | denotes | X2 and O2 | |
34 | 784-793 | Species | denotes | 2019-nCov | Tax:2697049 |
38 | 423-428 | Chemical | denotes | ADMET | |
40 | 49-61 | Disease | denotes | TTD diseases | MESH:D003141 |
41 | 71-92 | Disease | denotes | inflammatory diseases | MESH:D007249 |
42 | 94-100 | Disease | denotes | asthma | MESH:D001249 |
43 | 102-139 | Disease | denotes | chronic obstructive pulmonary Disease | MESH:D029424 |
44 | 249-258 | Disease | denotes | pneumonia | MESH:D011014 |
45 | 862-870 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T23 | 122-131 | UBERON:0002048 | denotes | pulmonary |
T24 | 148-153 | SO:0000276 | denotes | miRNA |
T25 | 172-176 | PR:000005265 | denotes | CDK7 |
T26 | 263-267 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T27 | 271-281 | GO:0010467 | denotes | expression |
T28 | 456-465 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T29 | 520-524 | CHEBI:23888;CHEBI:23888 | denotes | drug |
T30 | 549-565 | UBERON:0001555 | denotes | gastrointestinal |
T31 | 674-676 | CHEBI:15379;CHEBI:15379 | denotes | O2 |
T32 | 784-793 | SP_7 | denotes | 2019-nCov |
T33 | 841-845 | CHEBI:23888;CHEBI:23888 | denotes | drug |
T34 | 862-870 | SP_7 | denotes | COVID-19 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T2 | 282-290 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T3 | 822-830 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T6 | 71-92 | Disease | denotes | inflammatory diseases | http://purl.obolibrary.org/obo/MONDO_0021166 |
T7 | 94-100 | Disease | denotes | asthma | http://purl.obolibrary.org/obo/MONDO_0004979 |
T8 | 102-139 | Disease | denotes | chronic obstructive pulmonary Disease | http://purl.obolibrary.org/obo/MONDO_0005002 |
T9 | 249-258 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
T10 | 862-870 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T8 | 23-32 | http://purl.obolibrary.org/obo/SO_0000418 | denotes | signaling |
T9 | 390-396 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
T10 | 534-538 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
T11 | 663-665 | http://purl.obolibrary.org/obo/CLO_0050050 | denotes | S1 |
T12 | 704-707 | http://purl.obolibrary.org/obo/CLO_0007875 | denotes | MS1 |
T13 | 704-707 | http://purl.obolibrary.org/obo/CLO_0052410 | denotes | MS1 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T4 | 49-52 | Chemical | denotes | TTD | http://purl.obolibrary.org/obo/CHEBI_73659 |
T5 | 182-184 | Chemical | denotes | TF | http://purl.obolibrary.org/obo/CHEBI_74862 |
T6 | 282-290 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T7 | 520-524 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T8 | 659-661 | Chemical | denotes | M3 | http://purl.obolibrary.org/obo/CHEBI_51083|http://purl.obolibrary.org/obo/CHEBI_53453 |
T10 | 674-676 | Chemical | denotes | O2 | http://purl.obolibrary.org/obo/CHEBI_15379 |
T11 | 822-830 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T12 | 841-845 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 94-100 | Phenotype | denotes | asthma | http://purl.obolibrary.org/obo/HP_0002099 |
T2 | 102-139 | Phenotype | denotes | chronic obstructive pulmonary Disease | http://purl.obolibrary.org/obo/HP_0006510 |
T3 | 249-258 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T10 | 9-40 | http://purl.obolibrary.org/obo/GO_0033211 | denotes | adipocytokine signaling pathway |
T11 | 9-40 | http://purl.obolibrary.org/obo/GO_0033210 | denotes | adipocytokine signaling pathway |
T12 | 9-40 | http://purl.obolibrary.org/obo/GO_0033209 | denotes | adipocytokine signaling pathway |
T13 | 23-40 | http://purl.obolibrary.org/obo/GO_0007165 | denotes | signaling pathway |
T14 | 23-32 | http://purl.obolibrary.org/obo/GO_0023052 | denotes | signaling |
T15 | 182-184 | http://purl.obolibrary.org/obo/GO_0000981 | denotes | TF |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T13 | 192-291 | Sentence | denotes | QFPD contained 257 specific targets in addition to HCoV, pneumonia and ACE2 co-expression proteins. |
T14 | 292-409 | Sentence | denotes | Then, network topology analysis of the five components-target-pathway-disease networks yielded 67 active ingredients. |
T15 | 410-624 | Sentence | denotes | In addition, ADMET estimations showed that 20 compounds passed the stringent lead-like criteria and in silico drug-likeness test with high gastrointestinal absorption and the median lethal dose (LD50 > 1600 mg/kg). |
T16 | 625-831 | Sentence | denotes | Moreover, 4 specific ingredients (M3, S1, X2 and O2) and 5 common ingredients (MS1, MX16, SX1, WO1 and XO1) of QFPD presented good molecular docking score for 2019-nCov structure and non-structure proteins. |
LitCovid-PD-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glyco_epitope_db_id |
---|---|---|---|---|---|
T1 | 720-723 | GlycoEpitope | denotes | WO1 | http://www.glycoepitope.jp/epitopes/AN0690 |